No Detail Found!

A prospective study on medication and total parenteral nutrition practices at a Neonatal Intensive Care Unit

Author(s)
Vijayakumar Arumugam Department of Pharmacy Practice, Pharmacy Services, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu
Shaima Kattungal Arunan Department of Pharmacy Practice, Maharishi Markandeshwar College of Pharmacy, Ambala, Haryana
Ganesh Pandian Balasubramanian Department of Clinical Pharmacy and Pharmacy Practice, Unit of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, AIMST University, Semeling, Kedah, Malaysia
Sireesha Paruchuri Department of Pharmacy Practice, Vaagdevi College of Pharmacy, Warangal, Telangana, India
Abstract
Background: Neonates are vulnerable population and at high risk of developing drug-related problems. The extremely low birth weight (ELBW) infants require extended hospital stay in the Neonatal Intensive Care Unit (NICU). This study was aimed to evaluate the medications and total parenteral nutrition (TPN) practices at a NICU and to evaluate the clinical significance of medicine management made by the pharmacist and to assess the perception of healthcare professionals. Materials and Methods: It is a prospective observational study conducted for 7 months in the NICU of a multidisciplinary advanced super specialty hospital, accredited by the National Accreditation Board for Hospitals and Healthcare. This study is approved by the Institutional Ethics Committee. A total of 51 neonates who met inclusion criteria were included in this study. Data were collected, and all statistical analyses were performed using the GraphPad Prism 6 Demo. Variables were compared with rho Spearman nonparametric correlations and paired t-tests. Results: The present study showed that after administration of TPN, there was a significant change in the birth weight only in ELBW and very low birth weight (VLBW) neonates (P < 0.05). The average weight gain was more in the ELBW and VLBW groups. The study also measured the height of the preterm neonates before and after administration of TPN, and it was observed that VLBW group showed a significant increase in the height after administration of TPN (P < 0.05). About 0.27 cm average increase was observed from the VLBW group. Statistical analysis showed that head circumference gain after TPN administration was significant for birth weight <1000 g and 1000-1500 g neonates (P value 0.0192, 0.0001, respectively). Conclusion: TPN and medication practices at the NICU should be highly monitored for avoiding medication errors, drug interactions, and mortality rate in neonates. The most effective method can be achieved when a clinical pharmacist become a part of it.
Publication Details
Page(s) 142-149
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
Neonatal Intensive Care Unit, Neonates, Medication error, Total Parenteral Nutrition, Adverse Drug Reaction
References
. .. [Last Accessed 2015 June, 11 : .
Birth Preterm . .. [Last Accessed 2015 June, 15 : .
Stavroudis TA,Shore AD,Morlock L,Hicks RW,Bundy D,Miller MR .2010 .NICU medication errors: Identifying a risk profile for medication errors in the neonatal intensive care unit. J Perinatol, 30 : 459-68.
Lee HC,Bennett MV,Schulman J,Gould JB .2013 .Accounting for variation in length of NICU stay for extremely low birth weight infants. J Perinatol, 33 : 872-6.
Roger W,Cate W. .2012 .Clinical Pharmacy and Therapeutics. , : .
Heird WC,Driscoll JM,Schullinger JN,Grebin B,Winters RW .1972 .Intravenous alimentation in pediatric patients. J Pediatr, 80 : 351-72.
Mirtallo JM .2012 .36 2 Suppl: 62S.. JPEN J Parenter Enteral Nutr, : .
Kaushal R,Bates DW,Landrigan C,McKenna KJ,Clapp MD,Federico F .2001 .Medication errors and adverse drug events in pediatric inpatients. JAMA, 285 : 2114-20.
Apkon M,Leonard J,Probst L,DeLizio L,Vitale R .2004 .Design of a safer approach to intravenous drug infusions: Failure mode effects analysis. Qual Saf Health Care, 13 : 265-71.
Bates DW,Cullen DJ,Laird N,Petersen LA,Small SD,Servi D .1995 .Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA, 274 : 29-34.
. .Suite of Safety Software for the Alaris System. [Last Accessed 2015 May, 14 : .
Malashock CM,Shull SS,Gould DA .2004 .Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm, 39 : 460-9.
Leape LL,Kabcenell AI,Gandhi TK,Carver P,Nolan TW,Berwick DM .2000 .Reducing adverse drug events: Lessons from a breakthrough series collaborative. Jt Comm J Qual Improv, 26 : 321-31.
Leape LL .1994 .Error in medicine. JAMA, 272 : 1851-7.
Goldman DA,Maki DG,Rhame FS,Kaiser AB,Tenney JH,Bennett JV .1973 .Guidelines for infection control in intravenous therapy. Ann Intern Med, 79 : 848-50.
Williams WW .1985 .Infection control during parenteral nutrition therapy. JPEN J Parenter Enteral Nutr, 9 : 735-46.
Dickinson GM,Bisno AL .1989 .Infections associated with indwelling devices: Infections related to extravascular devices. Antimicrob Agents Chemother, 33 : 602-7.
Sacks GS .2011 .Microbial contamination of parenteral nutrition - how could it happen?. JPEN J Parenter Enteral Nutr, 35 : 432.
Wells BG,Dipiro JT,Dipiro TV. Pharmacotherapy,Handbook TV. Pharmacotherapy .2009 .. , : .
Chaudhari S,Kadam S. .2006 .Total parenteral nutrition in neonates. Indian Pediatr, 43 : 953-64.
Gómez de Orgaz MC,Sánchez Luna M,Sanjurjo Sáez M. M .2013 .Aggressive parenteral nutrition and growth velocity in preterm infants. Nutr Hosp, 28 : 2128-34.
Fusch C,Bauer K,Böhles HJ,Jochum F,Koletzko B,Krawinkel M .2009 .. on parenteral nutrition, chapter 13. Ger Med Sci, 7 : Doc15.
Schellack N,Gous AG .2011 .Antibiotic prescribing patterns in a neonatal intensive care unit. South Afr J Epidemiol Infect, 26 : 267-70.
Zingg W,Tomaske M,Martin M. .2012 .Risk of parenteral nutrition in neonates - An overview. Nutrients, 4 : 14905-03.
Vijayakumar A,Ganesh PB .2013 .A cross‑sectional study on patients with enteral nutrition. Int J Pharm Pharm Sci, 5 : 101-3.
Cordero L,Kuehn L,Kumar RR,Mekhjian HS .2004 .Impact of computerized physician order entry on clinical practice in a newborn intensive care unit. J Perinatol, 24 : 88-93.
Simmer K,Rakshasbhuvankar A,Deshpande G .2013 .Standardised parenteral nutrition. Nutrients, 5 : 10587-0.
Nuckols TK,Bower AG,Paddock SM,Hilborne LH,Wallace P,Rothschild JM .2008 .Programmable infusion pumps in ICUs: An analysis of corresponding adverse drug events. J Gen Intern Med, 23(Suppl 1) : 41-5.
Jiang SP,Chen J,Zhang XG,Zhao XY,QW XY .2014 .Implementation of pharmacists' interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Ther Clin Risk Manag, 10 : 861-6.
Starr SE .1985 .Antimicrobial therapy of bacterial sepsis in the newborn infant. J Pediatr, 106 : 1043-8.
.2014 .How to optimize the evaluation and use of antibiotics in neonates. Early Hum Dev, 90(Suppl 1) : S10-2.
Cransac A,Samama D,Lazzarotti A,Hugueny J,Sgro C,Ferdynus C .2013 .Identification of relevant drug interaction in neonatal intensive care units. Eur J Hosp Pharm, 20 : 1136.
Mackay MW,Cash J,Farr F,Holley M,Jones K,Boehme S K .2009 .Improving pediatric outcomes through intravenous and oral medication standardization. J Pediatr Pharmacol Ther, 14 : 226-35.
0

Citations

0

Downloads

10

Views